References
1. Lee SH, Tai CT, Hsieh MH, et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: Implication for catheter ablation. J Am Coll Cardiol 2005;46:1054–9.
2. Ulphani JS, Arora R, Cain JH, et al. The ligament of Marshall as a parasympathetic conduit. Am J Physiol Heart Circ Physiol 2007;293:1629–35.
3. Kim DT, Lai AC, Hwang C, et al. The ligament of Marshall: A structural analysis in human hearts with implications for atrial arrhythmias. J Am Coll Cardiol 2000;36:1324–7.
4. Kamanu S, Tan AY, Peter CT, et al. Vein of Marshall activity during sustained atrial fibrillation. J Cardiovasc Electrophysiol 2006;17:839–46.
5. Báez-Escudero JL, Keida T, Dave AS, et al. Ethanol infusion in the vein of Marshall leads to parasympathetic denervation of the human left atrium: implications for atrial fibrillation. J Am Coll Cardiol 2014;63:1892–1901.
6. Hayashi T, Fukamizu S, Mitsuhashi T, et al. Peri-Mitral Atrial Tachycardia Using the Marshall Bundle Epicardial Connections. J Am Coll Cardiol EP 2016;2:27–35.
7. Vlachos K, Denis A, Takigawa M, et al. The role of Marshall bundle epicardial connections in atrial tachycardias after atrial fibrillation ablation. Heart Rhythm 2019;16:1341–7.
8. Jais P, Hocini M, Hsu LF, et al. Technique and results of linear ablation at the mitral isthmus. Circulation 2004;110:2996–3002.
9. Knecht S, Hocini M, Wright M, et al. Left atrial linear lesions are required for successful treatment of persistent atrial fibrillation. Eur Heart J 2008;29:2359–66.
10. Knecht S, Wright M, Sacher F, et al. Relationship between perimitral and peritricuspid conduction times. Heart Rhythm 2008;5:400–5.
11. Valderrábano M, Liu X, Sasaridis C, et al. Ethanol infusion in the vein of Marshall: Adjunctive effects during ablation of atrial fibrillation. Heart Rhythm 2009;6:1552–8.
12. Báez-Escudero JL, Morales PF, Dave AS, et al. Ethanol infusion in the vein of Marshall facilitates mitral isthmus ablation. Heart Rhythm 2012;9:1207–15.
13. Liu CM, Lo LW, Lin YJ, et al. Long-term efficacy and safety of adjunctive ethanol infusion into the vein of Marshall during catheter ablation for nonparoxysmal atrial fibrillation. J Cardiovasc Electrophysiol 2019;30:1215–28.
14. Takigawa M, Vlachos K, Martin CA, et al. Acute and mid-term outcome of ethanol infusion of vein of Marshall for the treatment of perimitral flutter. Europace 2020;22:1252–60.
15. Kawaguchi N, Okishige K, Yamauchi Y, et al. Clinical impact of ethanol infusion into the vein of
Marshall on the mitral isthmus area evaluated by atrial electrograms recorded inside the coronary sinus. Heart Rhythm 2019;16:1030–8
16. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med 2015;372:1812‐1822.
17. Valderrábano M, Peterson LE, Bunge R, et al. Vein of Marshall ethanol infusion for persistent
atrial fibrillation: VENUS and MARS clinical trial design. Am Heart J 2019;215:52–61.
18. Valderrábano M, Peterson LE, Swarup V, et al. Effect of catheter ablation with vein of Marshall ethanol infusion vs catheter ablation alone on persistent atrial fibrillation: The VENUS randomized clinical trial. JAMA 2020;324:1620–8.
19. Nakashima T, Pambrun T, Vlachos K, et al. Impact of Vein of Marshall Ethanol Infusion on
Mitral Isthmus Block. Circ Arrhythm Electrophysiol 2020;13:e008884.
20. Yamaguchi T, Fukui A, Node K, et al. Bipolar voltage mapping for the evaluation of atrial substrate: Can we overcome the challenge of directionality? J Atr Fibrillation 2019;11:2116.